Landmark Bio

Landmark Bio is a cell and gene therapy manufacturing company dedicated to bridging the gap between groundbreaking research and patient-ready therapies.

Established as a collaborative endeavour by leaders from academia, the life sciences industry, and renowned research hospitals, Landmark Bio aims to accelerate the development and industrialisation of next-generation genomic medicines. By addressing barriers in drug development, the company provides accessible capabilities, expertise, and collaborative platforms to advance manufacturing technologies for emerging therapies.

Key Products and Services

Process and Analytical Development: Designing and optimising processes to ensure the efficacy and safety of therapies.

Formulation Development: Creating stable and effective formulations for therapeutic products.

Cell and Gene Therapy Manufacturing: Producing advanced cell and gene therapies under stringent quality standards.

Fill and Finish: Providing aseptic filling and final product preparation services.

Quality Control Testing: Conducting comprehensive testing to maintain product integrity and compliance.

CMC Regulatory and Drug Development Consulting: Offering guidance on chemistry, manufacturing, and controls (CMC) to navigate regulatory landscapes.

IND-Enabling Services: Assisting in the preparation and submission of Investigational New Drug (IND) applications.

Technology Development: Innovating and implementing new technologies to enhance therapeutic development and manufacturing.

With a mission to translate groundbreaking research into life-changing therapies, Landmark Bio stands at the forefront of the advanced therapy landscape. By fostering collaboration and innovation, the company plays a pivotal role in bringing cutting-edge treatments from the laboratory to patients in need.